322 filings
8-K
BSTC
Biospecifics Technologies Corp.
2 Dec 20
BioSpecifics Announces Completion of Acquisition by Endo Pharmaceuticals
9:22am
8-K
BSTC
Biospecifics Technologies Corp.
9 Nov 20
BioSpecifics Reports Third Quarter 2020 Financial and Operating Results
8:14am
8-K
BSTC
Biospecifics Technologies Corp.
19 Oct 20
BioSpecifics to be Acquired by Endo Pharmaceuticals
9:23am
8-K
BSTC
Biospecifics Technologies Corp.
14 Sep 20
Regulation FD Disclosure
7:32am
8-K
BSTC
Biospecifics Technologies Corp.
31 Aug 20
Entry into a Material Definitive Agreement
5:02pm
8-K
37nzb4 yy
11 Aug 20
Regulation FD Disclosure
8:01am
8-K
dd6q5rw
10 Aug 20
BioSpecifics Reports Second Quarter 2020 Financial and Operating Results
8:00am
8-K
2jfj6pxr1xowrcwwk
20 Jul 20
BioSpecifics Appoints Alex Monteith as Chief Business Officer
7:25am
8-K
87h9sc
14 Jul 20
Regulation FD Disclosure
4:15pm
8-K
9t0gagmqnxt oxuch
15 Jun 20
Amendments to Articles of Incorporation or Bylaws
8:01am
8-K
5f0 92en39x
12 Jun 20
Regulation FD Disclosure
6:27am
8-K
ri462
8 Jun 20
Departure of Directors or Certain Officers
11:22am
8-K
fxsoy4 70
11 May 20
BioSpecifics Reports First Quarter 2020 Financial and Operating Results
8:36am
8-K
16iqr78c
11 May 20
BioSpecifics Names Joseph Truitt as Permanent Chief Executive Officer
8:32am
8-K
xwq8gv m9nagzo
10 Apr 20
Entry into a Material Definitive Agreement
4:35pm
8-K
gz91ys
9 Apr 20
BioSpecifics Appoints Joseph Truitt as Interim Chief Executive Officer
8:11am
8-K
98b24b7fzmrfux gmo
23 Mar 20
Building a next-generation company on the foundation of our collagenase-based therapies MARCH 2020
3:50pm
8-K
uvn m3lpef
16 Mar 20
BioSpecifics Reports Fourth Quarter and Full Year 2019 Financial and Operating Results
4:14pm
8-K
3lifq1hblqe5rwr4y8ym
13 Jan 20
Regulation FD Disclosure
6:37am
8-K
br6nxbwh
7 Jan 20
Termination of a Material Definitive Agreement
5:15pm